# Comprehensive Proteomic Profiling Reveals Dysregulation of Angiogenesis and Inflammatory Pathways in the Brains of SIRT3 Knockout Mice

**Authors:** Qingping He, Samia Khan, Linlin Wang, Gordon C. Ibeanu, P. Andy Li

PMC · DOI: 10.3390/brainsci16030270 · Brain Sciences · 2026-02-28

## TL;DR

This study shows that the absence of SIRT3 in mice leads to changes in brain proteins related to blood vessel growth, cell death, and inflammation, suggesting a link to neurodegeneration.

## Contribution

The study provides the first comprehensive proteomic analysis of SIRT3's role in regulating brain angiogenesis, apoptosis, and inflammation pathways.

## Key findings

- SIRT3 knockout mice showed suppressed angiogenic proteins and altered apoptotic and stress-related proteins.
- Increased inflammatory mediators linked to glial activation and neurodegeneration were observed in SIRT3-deficient brains.
- SIRT3 deficiency disrupts immune surveillance and vascular remodeling proteins in the brain.

## Abstract

Background: Sirtuin 3 (SIRT3), a mitochondrial NAD+-dependent deacetylase, plays a central role in regulating mitochondrial metabolism, oxidative stress, and cell survival. Although SIRT3 has been implicated in angiogenesis, apoptosis, and inflammation, its global proteomic impact on the brain remains unclear. This study aimed to systematically characterize alterations in angiogenesis-, apoptosis-, chemokine-, and cytokine-related proteins in the brains of SIRT3 knockout (SIRT3 KO aka SIRT3−/−) mice compared with wild-type (WT) controls. Methods: Adult male C57BL/6 WT and SIRT3 KO mice were analyzed using proteome profiler antibody microarrays covering 53 angiogenesis factors, 21 apoptosis markers, 28 chemokines, and 111 cytokines. Protein expression changes were quantified by chemiluminescence imaging and densitometric analysis. Results: The results showed a distinct suppression of angiogenic proteins (amphiregulin, angiogenin, DPPIV, GM-CSF, IGFBP-2, IGFBP-3, IL-1β, PDGF-AA, PDGF-BB, proliferin, serpin F1, thrombospeondin-2, TIMP-4, and VEGF-B), activation of both pro-apoptotic (BAD, cytochrome c, Smac/DIABLO, HIF-1α, Fas, TNF R1, and TRAILR2) and anti-apoptotic, stress-related proteins (Bcl-x, catalase, HO/HMOX2, HSP27, HSP70, and MCL1) in the SIRT3 KO animals compared with the WT controls. Notably, SIRT3 deficiency was associated with increased expression of inflammatory mediators linked to glial activation and neurodegeneration (BLC/CCL13, LIX/CXCL5, MIG/CXCL9, chitinase 3-like 1, CCL22/MDC, IL-6, myeloperoxidase, osteopontin, RBP4, Reg3G, and TNF-α), alongside disturbed proteins involved in immune surveillance and vascular remodeling (6Ckine/CCL21, chemerin, DF, EGF, fractalkine/CX3CL1, HGF, IGFBP-6, IL-16, and I-TAC). Conclusions: Collectively, these findings demonstrate that SIRT3 is a key regulator of mitochondrial-dependent vascular, apoptotic, and neuroimmune pathways in the brain, and that its loss creates a molecular environment consistent with heightened vulnerability to neurodegenerative processes.

## Linked entities

- **Genes:** SIRT3 (sirtuin 3) [NCBI Gene 23410]
- **Proteins:** LOC102930967 (angiogenin-2), DPP4 (dipeptidyl peptidase 4), CSF2 (colony stimulating factor 2), IGFBP2 (insulin like growth factor binding protein 2), IGFBP3 (insulin like growth factor binding protein 3), IL1B (interleukin 1 beta), pdgfaa (platelet-derived growth factor alpha polypeptide a), pdgfbb (platelet derived growth factor subunit Bb), SERPINF1 (serpin family F member 1), TIMP4 (TIMP metallopeptidase inhibitor 4), VEGFB (vascular endothelial growth factor B), BAD (BCL2 associated agonist of cell death), Cyt-c-d (Cytochrome c distal), HIF1A (hypoxia inducible factor 1 subunit alpha), FAS (Fas cell surface death receptor), TNFRSF1A (TNF receptor superfamily member 1A), TNFRSF10B (TNF receptor superfamily member 10b), BCL2L1 (BCL2 like 1), Cat (Catalase), HSPB1 (heat shock protein family B (small) member 1), HSPA1A (heat shock protein family A (Hsp70) member 1A), MCL1 (MCL1 apoptosis regulator, BCL2 family member), IL6 (interleukin 6), RBP4 (retinol binding protein 4), REG3G (regenerating family member 3 gamma), TNF (tumor necrosis factor), RARRES2 (retinoic acid receptor responder (tazarotene induced) 2), CFD (complement factor D), EGF (epidermal growth factor), HGF (hepatocyte growth factor), IGFBP6 (insulin like growth factor binding protein 6), IL16 (interleukin 16), CXCL11 (C-X-C motif chemokine ligand 11)

## Full-text entities

- **Genes:** Ptx3 (pentraxin related gene) [NCBI Gene 19288] {aka TSG-14}, Csf3 (colony stimulating factor 3 (granulocyte)) [NCBI Gene 12985] {aka Csfg, G-CSF, MGI-IG}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Cxcl16 (C-X-C motif chemokine ligand 16) [NCBI Gene 66102] {aka 0910001K24Rik, CXCL16v1, CXCL16v2, SR-PSOX, Zmynd15, b2b498Clo}, Ccl21a (C-C motif chemokine ligand 21 (serine)) [NCBI Gene 18829] {aka 6CKBAC2, 6Ckine, ALP, CKb9, Gm1987, SCYA21a}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, Flt3l (FMS-like tyrosine kinase 3 ligand) [NCBI Gene 14256] {aka Flt3lg, Ly72L}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, Rarres2 (retinoic acid receptor responder (tazarotene induced) 2) [NCBI Gene 71660] {aka 0610007L05Rik}, Spp1 (secreted phosphoprotein 1) [NCBI Gene 20750] {aka 2AR, Apl-1, BNSP, BSPI, Bsp, ETA-1}, Hmox2 (heme oxygenase 2) [NCBI Gene 15369] {aka HO-2, HO2}, Rbp4 (retinol binding protein 4, plasma) [NCBI Gene 19662] {aka Rbp-4}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Angpt1 (angiopoietin 1) [NCBI Gene 11600] {aka 1110046O21Rik, Ang-1, Ang1}, Il33 (interleukin 33) [NCBI Gene 77125] {aka 9230117N10Rik, Il-33, Il1f11, NF-HEV}, Endog (endonuclease G) [NCBI Gene 13804], Mcl1 (myeloid cell leukemia sequence 1) [NCBI Gene 17210] {aka Gm52627, Mcl-1}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Mpo (myeloperoxidase) [NCBI Gene 17523] {aka mKIAA4033}, Txn1 (thioredoxin 1) [NCBI Gene 22166] {aka ADF, Trx1, Txn}, Il27 (interleukin 27) [NCBI Gene 246779] {aka IL-27, IL-27-A, IL-27p28, IL27-A, Il30, p28}, Areg (amphiregulin) [NCBI Gene 11839] {aka AR, Mcub, Sdgf}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Thbs2 (thrombospondin 2) [NCBI Gene 21826] {aka TSP2, Thbs-2}, Postn (periostin, osteoblast specific factor) [NCBI Gene 50706] {aka A630052E07Rik, OSF-2, Osf2, PLF, PN}, Apcs (amyloid P component, serum) [NCBI Gene 20219] {aka Sap}, Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, Il13 (interleukin 13) [NCBI Gene 16163] {aka Il-13}, Cd14 (CD14 antigen) [NCBI Gene 12475], Cst3 (cystatin C) [NCBI Gene 13010] {aka CysC}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Sod2 (superoxide dismutase 2, mitochondrial) [NCBI Gene 20656] {aka MnSOD, Sod-2}, Arhgef5 (Rho guanine nucleotide exchange factor 5) [NCBI Gene 54324] {aka 2210412D05Rik, Tim1}, Casp8 (caspase 8) [NCBI Gene 12370] {aka CASP-8, FLICE, MACH, Mch5}, Bcl2l1 (BCL2-like 1) [NCBI Gene 12048] {aka Bcl(X)L, Bcl-XL, Bcl2l, BclX, bcl-x, bcl2-L-1}, Ccn4 (cellular communication network factor 4) [NCBI Gene 22402] {aka Elm1, Wisp1}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, SIRT7 (sirtuin 7) [NCBI Gene 51547] {aka SIR2L7}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, Prl2c2 (prolactin family 2, subfamily c, member 2) [NCBI Gene 18811] {aka Ghd2, MRP-1, PLF-1, Plf, Plf1}, Egf (epidermal growth factor) [NCBI Gene 13645], Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, Vegfb (vascular endothelial growth factor B) [NCBI Gene 22340] {aka VEGF-B, Vrf}, Il1rn (interleukin 1 receptor antagonist) [NCBI Gene 16181] {aka F630041P17Rik, IL-1ra}, Dpp4 (dipeptidylpeptidase 4) [NCBI Gene 13482] {aka Cd26, Dpp-4, THAM}, Ccl5 (C-C motif chemokine ligand 5) [NCBI Gene 20304] {aka MuRantes, RANTES, SISd, Scya5, TCP228}, Ang (angiogenin, ribonuclease, RNase A family, 5) [NCBI Gene 11727] {aka Ang1, Rnase5, Rnase5a}, Igfbp6 (insulin-like growth factor binding protein 6) [NCBI Gene 16012] {aka IGFBP-6}, Nlrc4 (NLR family, CARD domain containing 4) [NCBI Gene 268973] {aka 9530011P19Rik, CLAN, CLAN1, CLANA, CLANB, CLANC}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Cgas (cyclic GMP-AMP synthase) [NCBI Gene 214763] {aka E330016A19Rik, Mb21d1}, Cd160 (CD160 antigen) [NCBI Gene 54215] {aka By55}
- **Diseases:** cerebral ischemia (MESH:D002545), tumor (MESH:D009369), gliosis (MESH:D005911), multiple sclerosis (MESH:D009103), tissue injury (MESH:D017695), sepsis (MESH:D018805), hypoxia (MESH:D000860), Alzheimer's disease (MESH:D000544), asthma (MESH:D001249), hypoxic (MESH:D002534), neuronal dysfunction (MESH:D009461), Inflammation (MESH:D007249), liver fibrosis (MESH:D008103), ischemic injury (MESH:D017202), traumatic brain injury (MESH:D000070642), amyotrophic lateral sclerosis (MESH:D000690), neuronal dysfunction and degeneration (MESH:D009410), infection (MESH:D007239), injury to (MESH:D014947), ischemic stroke (MESH:D002544), cerebral ischemic stroke (MESH:D020521), metastasis (MESH:D009362), retinal degeneration (MESH:D012162), ischemic brain injury (MESH:D001930), epilepsy (MESH:D004827), neuroinflammation (MESH:D000090862), arthritis (MESH:D001168), neurotoxicity (MESH:D020258), Parkinson's disease (MESH:D010300), autoimmune, metabolic, cardiovascular, and neurodegenerative diseases (MESH:D019636), Huntington's disease (MESH:D006816), coronary artery disease (MESH:D003324), diabetes (MESH:D003920)
- **Chemicals:** NAD (MESH:D009243), glutathione (MESH:D005978), CO2 (MESH:D002245), ATP (MESH:D000255), Bis-Tris (MESH:C026272), glucose (MESH:D005947), nitrogen (MESH:D009584), BCA (MESH:C047117), hypochlorous acid (MESH:D006997), Li-COR (-), PVDF (MESH:C024865), retinol (MESH:D014801), fatty acid (MESH:D005227), NADPH (MESH:D009249), lipid (MESH:D008055), TCA (MESH:D014238)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024698/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024698/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024698/full.md

---
Source: https://tomesphere.com/paper/PMC13024698